UTHR.NASDAQUnited Therapeutics CORP
Form 4: UNITED THERAPEUTICS CEO Sells Shares
Sentiment:
Insider Transaction (Form 4)
Martine A Rothblatt, Chairperson & CEO and a Director of UNITED THERAPEUTICS Corp, sold 9,500 shares of common stock on August 5, 2026.
Summary
- Option exercise/conversion: acquired 9,500 Common Stock at $135.42 ($1,286,490) on August 5, 2026; holds 333,943 after (Indirect).
- Open-market sale: disposed of 200 Common Stock at $502.29 ($100,458) on August 5, 2026; holds 333,743 after (Indirect).
- Open-market sale: disposed of 80 Common Stock at $504.31 ($40,344) on August 5, 2026; holds 333,663 after (Indirect).
- Open-market sale: disposed of 160 Common Stock at $507.24 ($81,158) on August 5, 2026; holds 333,503 after (Indirect).
- Open-market sale: disposed of 160 Common Stock at $510.28 ($81,644) on August 5, 2026; holds 333,343 after (Indirect).
- Open-market sale: disposed of 80 Common Stock at $511.07 ($40,886) on August 5, 2026; holds 333,263 after (Indirect).
- Open-market sale: disposed of 529 Common Stock at $514.28 ($272,054) on August 5, 2026; holds 332,734 after (Indirect).
- Open-market sale: disposed of 205 Common Stock at $515.44 ($105,666) on August 5, 2026; holds 332,529 after (Indirect).
- Open-market sale: disposed of 386 Common Stock at $516.72 ($199,456) on August 5, 2026; holds 332,143 after (Indirect).
- Open-market sale: disposed of 557 Common Stock at $517.48 ($288,239) on August 5, 2026; holds 331,586 after (Indirect).
- Open-market sale: disposed of 1,891 Common Stock at $518.51 ($980,504) on August 5, 2026; holds 329,695 after (Indirect).
- Open-market sale: disposed of 1,496 Common Stock at $519.62 ($777,353) on August 5, 2026; holds 328,199 after (Indirect).
- Open-market sale: disposed of 1,011 Common Stock at $520.58 ($526,305) on August 5, 2026; holds 327,188 after (Indirect).
- Open-market sale: disposed of 1,385 Common Stock at $521.64 ($722,476) on August 5, 2026; holds 325,803 after (Indirect).
- Open-market sale: disposed of 939 Common Stock at $522.66 ($490,776) on August 5, 2026; holds 324,864 after (Indirect).
- Open-market sale: disposed of 261 Common Stock at $523.88 ($136,732) on August 5, 2026; holds 324,603 after (Indirect).
- Open-market sale: disposed of 160 Common Stock at $524.59 ($83,934) on August 5, 2026; holds 324,443 after (Indirect).
- Option exercise/conversion: disposed of 9,500 Stock Option on August 5, 2026; holds 198,910 after (Indirect).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $4,927,985 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Martine A Rothblatt — Director, Officer (Chairperson & CEO)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-05 | Option exercise/conversion | Common Stock | 9,500 | $135 | $1.3M | 333,943 |
| 2026-08-05 | Open-market sale | Common Stock | 200 | $502 | $100.5K | 333,743 |
| 2026-08-05 | Open-market sale | Common Stock | 80 | $504 | $40.3K | 333,663 |
| 2026-08-05 | Open-market sale | Common Stock | 160 | $507 | $81.2K | 333,503 |
| 2026-08-05 | Open-market sale | Common Stock | 160 | $510 | $81.6K | 333,343 |
| 2026-08-05 | Open-market sale | Common Stock | 80 | $511 | $40.9K | 333,263 |
| 2026-08-05 | Open-market sale | Common Stock | 529 | $514 | $272.1K | 332,734 |
| 2026-08-05 | Open-market sale | Common Stock | 205 | $515 | $105.7K | 332,529 |
| 2026-08-05 | Open-market sale | Common Stock | 386 | $517 | $199.5K | 332,143 |
| 2026-08-05 | Open-market sale | Common Stock | 557 | $517 | $288.2K | 331,586 |
| 2026-08-05 | Open-market sale | Common Stock | 1,891 | $519 | $980.5K | 329,695 |
| 2026-08-05 | Open-market sale | Common Stock | 1,496 | $520 | $777.4K | 328,199 |
| 2026-08-05 | Open-market sale | Common Stock | 1,011 | $521 | $526.3K | 327,188 |
| 2026-08-05 | Open-market sale | Common Stock | 1,385 | $522 | $722.5K | 325,803 |
| 2026-08-05 | Open-market sale | Common Stock | 939 | $523 | $490.8K | 324,864 |
| 2026-08-05 | Open-market sale | Common Stock | 261 | $524 | $136.7K | 324,603 |
| 2026-08-05 | Open-market sale | Common Stock | 160 | $525 | $83.9K | 324,443 |
| 2026-08-05 | Option exercise/conversion | Stock Option | 9,500 | — | — | 198,910 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-05 | Option exercise/conversion (9,500 shares) |
| 2026-08-05 | Open-market sale (200 shares) |
| 2026-08-05 | Open-market sale (80 shares) |
| 2026-08-05 | Open-market sale (160 shares) |
| 2026-08-05 | Open-market sale (160 shares) |
| 2026-08-05 | Open-market sale (80 shares) |
| 2026-08-05 | Open-market sale (529 shares) |
| 2026-08-05 | Open-market sale (205 shares) |
| 2026-08-05 | Open-market sale (386 shares) |
| 2026-08-05 | Open-market sale (557 shares) |
| 2026-08-05 | Open-market sale (1,891 shares) |
| 2026-08-05 | Open-market sale (1,496 shares) |
| 2026-08-05 | Open-market sale (1,011 shares) |
| 2026-08-05 | Open-market sale (1,385 shares) |
| 2026-08-05 | Open-market sale (939 shares) |
| 2026-08-05 | Open-market sale (261 shares) |
| 2026-08-05 | Open-market sale (160 shares) |
| 2026-08-05 | Option exercise/conversion (9,500 shares) |
Keywords
insider transaction, Form 4, UTHR, UNITED THERAPEUTICS Corp, bearish, Martine A Rothblatt
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.